Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Allergan spin-off

This article was originally published in The Tan Sheet

Executive Summary

Contact lens care, ophthalmic surgical businesses will be housed in new publicly traded company, Advanced Medical Optics, under stockholder spin-off expected to be completed by July, Allergan announces Jan. 22. Company points to divergent market growth rates, gross margin leverage, R&D intensity as reasons for separating pharma, device businesses. Since complete separation of Rx, surgical and contact lens care sales forces in 1998, it has become "more obvious that limited synergies in the office of the eye practitioner are no longer sufficient reason for these businesses to operate within one enterprise," company states. Lens care sales fell 7% to $77.4 mil. in Q4, dropped 9.6% to $297.1 mil. for 2001, "impacted by the loss in the fourth quarter of certain private-label contracts with mass merchandisers," firm says...

Related Content






Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts